Free UK Delivery on orders over £49

Loxicom 1.5mg/ml Oral Suspension for dogs

Item Number: LOXICOM

Sale Loxicom 1.5mg/ml Oral Suspension for dogs

Choose Your Options:

  • 100ml

    In Stock

    Was £39.49 Now £38.79

  • 10ml

    Estimated dispatch on Wednesday

    Was £10.75 Now £10.55

  • 2 x 100ml

    Was £59.75 Now £58.99

    Sorry, this product is not currently available to buy. This is likely because of a manufacturer delay. Call us on 01833 641112 for more information. We may also be able to suggest an alternative.
  • 32ml

    In Stock

    Was £17.89 Now £14.55

Total: £0.00

Choose options to add to basket

You are ordering a PRESCRIPTION ONLY medicine. Please do NOT continue unless you are sending us a valid prescription.



Browse other products from the Loxicom product range


Loxicom for the alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs

Data Sheets

Loxicom 1.5 mg/ml Oral Suspension Dogs Species:Dogs

Therapeutic indication:Pharmaceuticals: Anti-inflammatory preparations: Oral: Other NSAIDs

Active ingredient:Meloxicam

Product:Loxicom 1.5 mg/ml Oral Suspension Dogs

Product index:Loxicom 1.5 mg/ml Oral Suspension Dogs

Qualitative and quantitative composition

Each ml contains:

Active Substance: Meloxicam 1.5 mg

Excipients: Sodium Benzoate 1.5 mg

Pharmaceutical form

Pale yellow oral suspension.

Clinical particulars

Target species


Indications for use, specifying the target species

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.


Do not use in pregnant or lactating animals.

Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do no use in dogs less than 6 weeks of age.

Special warnings for each target species


Special precautions for use

Special precautions for use in animals

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions (frequency and seriousness)

Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

The frequency of adverse reactions is defined using the following convention:

  • very common (more than 1 in 10 animals treated displaying adverse reactions)
  • common (more than 1 but less than 10 animals in 100 animals treated)
  • uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
  • rare (more than 1 but less than 10 animals in 10,000 animals treated)
  • very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
  • Use during pregnancy, lactation or lay

    The safety of the veterinary medicinal product has not been established during pregnancy and lactation, (see contraindications)

    Interaction with other medicinal products and other forms of interaction

    Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Loxicom must not be administered in conjunction with other NSAIDs or glucocorticosteroids.

    Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.

    Amounts to be administered and administration route

    Oral use.

    To be administered with food or directly into the mouth.

    Shake well before use.

    Initial treatment is a single dose of 0.2 mg meloxicam/kg bodyweight (i.e. 1.33 ml/10 kg bodyweight) on the first day. Treatment is to be continued once daily by oral administration (at 24 hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg bodyweight (i.e. 0.667 ml/10 kg bodyweight).

    For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.

    Particular care should be taken with regard to the accuracy of dosing.

    The suspension can be given using either of the two measuring syringes provided in the package (depending on weight of dog). The syringes fit onto the bottle and have a kg-bodyweight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg bodyweight). Thus for the first day, twice the maintenance volume will be required. Alternatively therapy may be initiated with Loxicom 5 mg/ml solution for injection.

    A clinical response is normally seen within 3-4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

    Avoid introduction of contamination during use.

    Overdose (symptoms, emergency procedures, antidotes), if necessary

    In the case of overdose, symptomatic treatment should be initiated.

    Pharmacological particulars

    Pharmacotherapeutic Group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams).

    ATCvet code: QM01AC06

    Pharmacodynamic properties

    Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue. To a minor extent it also inhibits collagen-induced thrombocyte aggregation. In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).

    Pharmacokinetic particulars


    Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 4.5 hours. When the product is used according to the recommended dosage regime, steady state concentrations of meloxicam in plasma are reached on the second day of treatment.


    There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range in dogs. Approximately 97 % of meloxicam is bound to plasma proteins. The volume of distribution is 0.3 l/kg.


    Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound. Meloxicam is metabolised to an alcohol, an acid derivative and to several polar metabolites. All major metabolites have been shown to be pharmacologically inactive.


    Meloxicam is eliminated with a half-life of 24 hours. Approximately 75 % of the administered dose is eliminated via faeces and the remainder via urine.

    Pharmaceutical particulars

    List of Excipients

  • Sodium Benzoate
  • Glycerol
  • Povidone K30
  • Xanthan Gum
  • Disodium Phosphate Dihydrate
  • Sodium Dihydrogen Phosphate Dihydrate
  • Citric Acid Anhydrous
  • Simethicone Emulsion
  • Purified water
  • Incompatibilities

    None known.


    Shelf-life of the veterinary medicinal product as packaged for sale: 18 months

    Shelf-life after first opening the immediate packaging: 6 months

    Special precautions for storage

    This veterinary medicinal product does not require any special storage conditions.

    Nature and composition of immediate packaging

    The veterinary medicinal product is presented in 10 ml, 32 ml, 100 ml and 2 x100ml polyethylene screw bottles with HDPE/LDPE child resistant caps. Two polyethylene/polypropylene measuring syringes, a 1 ml and 5 ml syringe, are supplied with each bottle to ensure accurate dosing of small and large dogs.

    Each syringe is graduated in bodyweight, the 1 ml syringe is graduated from 0.5 kg to 15 kg and the 5 ml syringe for 2.5 kg to 75 kg.

    Special precautions for the disposal of unused veterinary medicinal product or waste material derived from the use of such products

    Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

    Marketing Authorisation Holder (if different from distributor)

    Norbrook Laboratories (Ireland) Limited, Rossmore Industrial Estate, Monaghan, Ireland

    Marketing Authorisation Number

    UK(GB): Vm 02000/5003

    UK(NI): EU/2/08/090/003, EU/2/08/090/004, EU/2/08/090/005, EU/2/08/090/032, EU/2/08/090/033

    Significant changes

    Date of the first authorisation or date of renewal

    Date of first authorisation: 10/02/2009

    Date of last renewal: 23/01/2019

    Date of revision of the text

    Detailed information on this veterinary medicinal product is available on the website of the European.

    Medicines Agency

    January 2019

    Any other information


    Legal category

    Legal category:POM-V


    GTIN description:Loxicom 1.5mg/ml for Dogs 10ml


    GTIN description:Loxicom 1.5mg/ml for Dogs 32ml


    GTIN description:Loxicom 1.5mg/ml for Dogs 100ml


    GTIN description:Loxicom 1.5 mg/ml Oral Suspension for Dogs 2 x100ml dual pack



    Shipping charges mainland UK zone1

    ValueWeightDelivery Charge
    Over £49.00Any WeightFREE
    Under £49.00No weight limit£4.50
    Under £49.00Under 250g£2.99

    Most orders are despatched the same day and standard delivery is 3 to 5 working days from despatch. FAST Expedited options are available.

    NB: Orders placed with faster delivery must be placed before 13:00 to ensure same day dispatch (excluding weekends and bank holidays). Please also check on the product page that the items ordered show 'In Stock' otherwise your order will be delayed until the stock becomes available, which in most cases will only be 24hrs.

    Estimated "Usually shipped in" information is shown against most products

    Overseas orders

    Postage outside of the UK is from £4.50

    Prescription Items

    Prescription items will be sent on receipt of a valid signed and dated prescription.

    Pick up

    We offer a pickup service for orders placed over the phone.

    Please ring us on 01833 641112 for more information.

    Refrigerated Items

    Refrigerated items will be sent by carrier or Royal Mail with coolpacks unless you pay for a premium for a refrigerated delivery. We will contact you prior to despatch for your instructions.


    We want you to be completely satisfied with any purchase. If not any item* can be returned to us within 14 days of receipt for exchange or refund Please give us a ring for a returns number on 01833 641112 or alternatively email [email protected] to obtain a returns number.

    *Due to legal requirements medicines may not be returned except to correct an error in despatch or in response to an "official recall". If an item is believed to be faulty it should be returned for inspection and it may be necessary to forward it to the manufacturers for testing before replacements or refunds can be authorised. This does not infringe legal rights. Please contact our customer services for a "Returns Number" which must appear on the outside of the package or it will not be accepted. We advise customers to use an insured method of shipping and to retain proof of despatch. We may refuse returns on products specially obtained or manufactured to order. Items must be returned unsoiled and unused and sent adequately packed and carriage paid.

    Frequently Asked Questions

    There have been no questions/answers for this product so far.

    Ask Question

    Ask a question about Loxicom 1.5mg/ml Oral Suspension for dogs